A Letter from Aaron Green: Driving OneMedNet's Vision
OneMedNet Corporation (NASDAQ: ONMD) has consistently demonstrated its leadership in the realm of AI-powered Real-World Data (RWD). Recently, Aaron Green, the President and CEO of OneMedNet, shared an enlightening letter to shareholders, outlining the strides the company has made and the direction it intends to pursue.
2025: A Year of Momentum
In his message, Green emphasized the significant progress made throughout the past year. OneMedNet is experiencing robust momentum in expanding its market presence while enhancing its revolutionary Real-World Data platform. Additionally, the company's commitment to developing AI-driven tools for data anonymization and de-identification across varied industries highlights its innovative approach.
Key Achievements for OneMedNet
The achievements that Green underscores are noteworthy:
- Onboarding Data Marketplaces: The company has successfully partnered with five major data marketplaces, significantly increasing its accessibility and reach.
- Expanding Data Network: OneMedNet boasts over 121 million clinical exams through its network, showcasing remarkable organic growth of approximately 5% annually.
- Innovative AI-Powered Platform: The federated iRWD™ platform employs cost-efficient AI tools, enabling efficient data curation for various sectors, including healthcare, finance, and telecom.
- Enhanced Brand Visibility: Increased participation in industry trade shows has significantly boosted stakeholder engagement and interest in OneMedNet’s services.
- Diverse Customer Engagement: A strong customer base, including leading life sciences organizations, continues to validate OneMedNet's regulatory-grade datasets for essential applications.
- Commitment to Compliance: OneMedNet ensures that its datasets meet rigorous FDA and international standards, providing essential real-world evidence for research and approvals.
- AI Innovations: The company supplies foundational data for AI model training in medical imaging, advancing precision medicine.
Why OneMedNet Stands Out
Unlike competitors who merely aggregate data, OneMedNet transforms raw information into valuable insights. It focuses on:
- AI-assisted De-identification: This enables safe data sharing across industries.
- Purpose-Built RWD: The datasets created are premium and tailored, reflecting both quality and intent.
- Regulatory-Grade Datasets: Attributes that ensure compliance and industry relevance.
- Longitudinal Tracking: Sensitive to care events, providing extended insights.
- High Satisfaction Rates: Reflects a commitment to quality and service towards leading organizations.
The Expanding Horizon
The demand for Real-World Data is at its peak as traditional clinical trial models undergo significant transformation. Regulatory bodies are increasingly endorsing the integration of Real-World Evidence (RWE) in the approval cycle, making it essential for companies like OneMedNet to lead the charge.
Recent analyses predict that generative AI and real-world data could generate a staggering $60 billion to $110 billion in annual value within the healthcare sector alone. This statistic showcases how OneMedNet is uniquely positioned to capitalize on this opportunity with its scalable and innovative solutions.
Subscription-Based Model for Future Growth
To enhance its revenue model, OneMedNet has introduced a subscription-based Data License Agreement structure, promoting Annual Recurring Revenue (ARR). This allows for near real-time data access through flexible licenses, aligning perfectly with the market's demand for reliable, high-quality data.
Looking Ahead: Pillars of Growth
Green concluded his letter by outlining the three foundational pillars of OneMedNet’s strategy: Platform, Partners, and People. The integration of these elements, alongside its innovative iRWD™ platform, positions OneMedNet for significant growth in the coming years.
To every shareholder, Green expresses gratitude for the unwavering support, emphasizing that while market fluctuations may not immediately reflect the company’s potential, the focus remains on building lasting value through strategic initiatives and relevant offerings in an evolving healthcare landscape.
Frequently Asked Questions
What is OneMedNet Corporation?
OneMedNet is a leader in AI-powered Real-World Data solutions, focused on transforming how data is utilized across various industries.
What recent achievements did OneMedNet share?
OneMedNet has onboarded five major data marketplaces and expanded its clinical exam repository significantly in the last year.
How does OneMedNet ensure data quality?
They provide premium, regulatory-grade datasets that comply with strict international standards, ensuring data reliability for various applications.
What is the significance of Real-World Data in healthcare?
RWD plays a critical role in modernizing clinical trials, regulatory processes, and advancing medical research through actionable insights.
How is OneMedNet positioned for future growth?
With a scalable platform and innovative AI capabilities, OneMedNet is uniquely positioned to capture emerging opportunities worth billions.
